nivolumab,ipilimumab,cabozantinib,sunitinib
bms,pfizer
['nivolumab', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'sarcoma', 'check,mate,276', 'ipilimumab', 'cabo ', 'nivo', 'cm-9er']
results of discontinued arm of cm-9er. triplets! #gu23 based in clinical case. 
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert